Expert Ratings for Alpha Tau Medical
Portfolio Pulse from Benzinga Insights
Alpha Tau Medical (NASDAQ:DRTS) received 4 analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish, and no bearish ratings. The average 12-month price target is $8.5, with a high of $9.00 and a low of $8.00, representing a 29.17% decrease from the previous target of $12.00. Analysts use various methods to determine their ratings, which are opinions and can vary.
December 15, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpha Tau Medical has a positive outlook from analysts with 3 bullish and 1 somewhat bullish ratings. The average price target is $8.5, a significant decrease from the previous $12.00.
The predominance of bullish ratings suggests a positive sentiment among analysts, which could lead to increased investor confidence and a potential short-term price increase. However, the decrease in the average price target may temper expectations and could indicate a more cautious outlook on the company's valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100